93
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Interpectoral Lymph Node Dissection Can Be Spared in pN0/N1 Invasive Breast Cancer Undergoing Modified Radical Mastectomy: Single-Institution Experience from Mainland China

, , , ORCID Icon, &
Pages 5855-5863 | Published online: 27 Jul 2021

References

  • Grossman F. Ueber die Axillaren Lymphdrusen: Inaugural Dissertation. [About the Axillary Lymph Glands: Inaugural Dissertation]. Berlin, Germany; 1896. German.
  • Rotter J. Zur topagraphie des mamma-carcinoma. Arch Klinische Chirurgie. 1899;58:346–356.
  • Estourgie SH, Nieweg OE, Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239(2):232–237. doi:10.1097/01.sla.0000109156.26378.9014745331
  • Komenaka IK, Bauer VP, Schnabel FR. Interpectoral nodes as the initial site of recurrence in breast cancer. Arch Surg. 2004;139(2):175–178. doi:10.1001/archsurg.139.2.17514769576
  • Isik A, Karavas E, Peker K, et al. Male Mondors disease is a rare entity. Breast J. 2016;22(6):700–701. doi:10.1111/tbj.1265727550206
  • Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer- a multicenter validation study. N Engl J Med. 1998;339(14):941–946. doi:10.1056/NEJM1998100133914019753708
  • Kuwajerwala NK, Feczko C, Dekhne N, et al. Comparison of lymphedema in patients with axillary lymph node dissections to those with sentinel lymphnode biopsy followed by immediate and delayed ALND. Am J Clin Oncol. 2013;36(1):20–23. doi:10.1097/COC.0b013e31823a495622157215
  • Isik A, Peker K, Firat D, et al. Importance of metastatic lymph node ratio in non-metastatic, lymph node-invaded colon cancer: a clinical trial. Med Sci Monit. 2014;20:1369–1375. doi:10.12659/MSM.89080425087904
  • Vrdoljak DV, Ramljak V, Muzina D, et al. Analysis of metastatic involvement of interpectoral (Rotter’s) lymph nodes related to tumor location, size, grade and hormone receptor status in breast cancer. Tumori J. 2005;91(2):177–181. doi:10.1177/030089160509100214
  • Joshi S, Noronha J, Hawaldar R, et al. Merits of level III axillary dissection in node-positive breast cancer: a prospective, single-institution study from India. J Glob Oncol. 2019;5:1–8. doi:10.1200/JGO.18.00165
  • Hammond ME, Hayes DF, Wolff AC, et al. American society of clinical oncology/college of American pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Oncol Pract. 2010;6:195–197. doi:10.1200/JOP.77700321037871
  • Yaziji H, Goldstein LC, Barry TS, et al. HER-2 testing in breast cancer using parallel tissue-based methods. JAMA. 2004;291:1972–1977. doi:10.1001/jama.291.16.197215113815
  • Blumgart EI, Uren RF, Nielsen PM, et al. Predicting lymphatic drainage patterns and primary tumour location in patients with breast cancer. Breast Cancer Res Treat. 2011;130(2):699–705. doi:10.1007/s10549-011-1737-221850393
  • Cody HS, Egeli RA, Urban JA. Rotter’s node metastases. Therapeutic and prognostic considerations in early breast carcinoma. Ann Surg. 1984;199(3):266–270. doi:10.1097/00000658-198403000-000036322707
  • Senofsky GM, Moffat FL, Davis K, et al. Total axillary lymphadenectomy in the management of breast cancer. Arch Surg. 1991;126(11):1336–1342. doi:10.1001/archsurg.1991.014103500260041747046
  • Giuliano AE, Ballman KV, McCall L, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American college of surgeons oncology group (alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264(3):413–420. doi:10.1097/SLA.000000000000186327513155
  • Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA. 2017;318(10):918–926. doi:10.1001/jama.2017.1147028898379